169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Use of pp2a phosphatase modulators in the treatment of mental disorders
#6602Therapeutic and diagnostic agents
#6603Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
#6604Methods of inhibiting a GPCR
#6605Use of coagulation proteins to lyse clots
#6606Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
#6607Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
#6608Tissue rejection
#6609Method of diagnosis of obesity
#6610Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
#6611Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof
#6612Modified t lymphocytes and uses therefor
#6613Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
#6614PGE-M as a biomarker of pulmonary inflammation
#6615Caries risk test for predicting and assessing the risk of disease
#6616Diagnostics and therapeutics for macular degeneration-related disorders
#6617Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
#6618Regulation of cell surface proteins
#6619Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
#6620Serum biomarkers in ischaemic heart disease
#6621Ischemic biomarkers and their use to predict adverse neurological events from surgery
#6622Methods, products and treatments for diabetes
#6623Use of IL-17F in diagnosis and therapy of airway inflammation
#6624Compositions and methods for diagnosing and treating neuropsychiatric disorders
#6625Short peptides from the ‘2loop’ of 7 transmembrane receptor which selectively modulate signal transduction
#6626Plasma polymerization of atomically modified surfaces
#6627Method for diagnosing alopecia
#6628C-reactive protein immunoassay and method
#6629Method for detecting perilymphatic fistula
#6630Diagnosis of sepsis
#6631Biomarkers of liver injury
#6632Methods for manipulating satiety
#6633Methods and compositions for polytopic vaccination
#6634Method for stimulating hair follicle cell proliferation
#6635CD39L3 and its role in diabetes
#6636Receptor
#6637Treatment of DNA damage related disorders
#6638Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
#6639Non-invasive assessment of intra-amniotic environment
#6640Protein for diagnosing diabetic retinopathy
#6641Use of GFAP for identification of intracerebral hemorrhage
#6642Diagnostic method for Celiac Sprue
#6643Method of evaluating a subject for risk or predisposition of reduced renal function over time
#6644Modulation of angiogenesis
#6645Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#6646Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
#6647Methods for distinguishing type-1 from type-2 diabetes
#6648Markers for sudden death in heart failure
#6649Cardiac hormones for assessing cardiovascular risk
#6650Screening method
#6651Sandwich immunoassay for identifying partial proANP peptides
#6652Methods of diagnosing and treating diabetes and insulin resistance
#6653Methods of using molecular constructs for detection of biochemical reactions
#6654Therapeutic polypeptides, nucleic acids encoding same, and methods of use
#6655Double stranded RNA receptor (dsRNA-R) and methods relating thereto
#6656Pathogenic gene for coronary artery disease
#6657Peptide-based immunization therapy for treatment of atherosclerosis
#6658Use of A33 antigens and JAM-it
#6659Calcium receptor-active molecules
#6660High performance liquid chromatography with an aqueous mobile phase for analysis of drug and its metabolite
#6661Ectopic pregnancy markers
#6662Methods of detecting a phenotype of a polymorphic protein
#6663Eukaryotic genes involved in adult lifespan regulation
#6664Methods of diagnosing and treating diabetes and insulin resistance
#6665NELL-1 enhanced bone mineralization
#6666Diagnosis and treatment of human kidney diseases
#6667Classifying and predicting glomerulosclerosis using a proteomics approach
#6668Assays for detecting small nuclear ribonucleoprotein particle assembly and survival of motor neurons activity
#6669IL1RL-1 as a cardiovascular disease marker and therapeutic target
#6670Diagnostics and therapeutics for glaucoma
#6671Novel human protein kinases and protein kinase-like enzymes
#6672Method for optimizing thiopurine efficacy and toxicity using mass spectrometry
#6673Variants of cytochrome c and methods of diagnosis of thrombocytopenia
#6674Compositions and methods for promoting or inhibiting angiogenesis
#6675Methods for treating inflammatory disorders using regulators of microvessel dilations
#6676Protein biopolymer markers predictive of insulin resistance
#6677Protein biopolymer markers predictive of insulin resistance
#6678Protein biopolymer markers predictive of insulin resistance
#6679Protein biopolymer markers predictive of insulin resistance
#6680Methods and compounds for promoting vessel regression
#6681Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
#6682Methods for detecting vasculopathies and tumors
#6683Interleukin-8 homologous polypeptides and therapeutic uses thereof
#6684Compositions and methods for preventing, treating and diagnosing diabetes
#6685Protein biopolymer markers predictive of insulin resistance
#6686Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease
#6687Diagnostic test
#6688Methods of assessing endothelial dysfunction using acute transient responses following fat administration
#6689Platelet biomarkers for the detection of disease
#6690Methionine sulfoxide antibodies
#6691Use of prostate specific antigen to predict drug response
#6692Reagent sets and gene signatures for renal tubule injury
#6693Compositions and methods for bone formation and remodeling
#6694Method of evaluating compound efficacious in treating obesity by using slc25a10
#6695Protein biopolymer markers indicative of insulin resistance
#6696Complement C3 precursor biopolymer markers indicative of insulin resistance
#6697Methods and kit for diagnosing tick borne illnesses
#6698Genetic markers associated with benign prostatic hyperplasia
#6699Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#6700Neuropeptide Y receptor Y5 and nucleic acid sequences
#6701Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
#6702Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
#6703Interleukin-13 as a cardiovascular disease marker
#6704Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements
#6705Diagnosis
#6706Methods for detecting TAFIa or TAFIai
#6707Novel composition and methods for the treatment of psoriasis
#6708Nucleic acid sequences differentially expressed in cancer tissue
#6709Method for diagnosing liver diseases
#6710DNA sequence and recombinant production of the grass pollen allergen Phl p 4
#6711Methods and kits for detecting heparin/platelet factor 4 antibodies
#6712Antibody assay methods to assess risk for TIA/stroke
#6713Assay methods for immediate diagnosis of cause of stroke
#6714Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
#6715Notch-origin polypeptides and biomarkers and reagents using the same
#6716Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs
#6717Zinc alpha-2-glycoprotein as indicator of cancer
#6718Nucleic acids and polypeptides useful for diagnosing complications of pregnancy
#6719Method of diagnosis and agents useful for same
#6720Method of adjudicating on acute aortic dissection and reagent for adjudication
#6721Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#6722Glucose-transport related genes, polypeptides, and methods of use thereof
#6723Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality
#6724Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
#6725Human B7 polypeptide B7-H3A
#6726Methods of diagnosing inflammatory bowel disease
#6727Model of bone disease amenable to high-throughput screening
#6728Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
#6729Secreted peptides
#6730Method for diagnosing and monitoring critically ill patients
#6731Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#6732Gene expression and genetic changes implicated in alcoholism
#6733Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease
#6734Computational knowledge model to discover molecular causes and treatment of diabetes mellitus
#6735Apparatus and methods for risk stratification of patients with chest pain of suspected cardiac origin
#6736Proteins involved in the regulation of energy homeostasis
#6737Novel serine protease
#6738Determination method for calprotectin and the use of calprotectin as a predictive marker for cardiovascular disease
#6739Methods for treating cardiac disease by modifying an N-terminal domain of troponin I
#6740Methods for drug discovery disease treatment, and diagnosis using metabolomics
#6741Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6742Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#6743Platelet biomarkers for the detection of disease
#6744DII4 antagonists, assays, and therapeutic methods thereof
#6745Method for interpreting tandem mass spectrometry data for clinical diagnosis
#6746Methods of identifying modulators of NMUR2-mediated activity
#6747Glycated insulin as a biomarker for diagnosis and monitoring of diabetes
#6748Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
#6749Relevance of achieved levels of markers of systemic inflammation following treatment
#6750Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis
#6751Preventives/remedies for neurodegenerative diseases
#6752Methods for detecting sepsis
#6753Marker for inflammatory conditions
#6754Cancer-linked gene as target for chemotherapy
#6755Compositions and methods for the treatment of body weight disorders, including obesity
#6756RICK3 nucleic acids and proteins
#6757Polymorphisms of the OCTN1 cation transporters associated with inflammatory bowel disorders
#6758Method and markers for the diagnosis of Graft versus Host Disease (GvHD)
#6759Modulation of deubiquitinase family members
#6760Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
#6761Method for diagnosing inflammatory bowel disease
#6762Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692, 58874, 252, 304, 1980, 14717, 9941, 1941, 19310, or 17832
#6763Methods of diagnosing cardiovascular disease
#6764Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
#6765Signals and molecular species involved in senescence
#6766Kinase inhibitors for the treatment of diabetes and obesity
#6767MK2 interacting proteins
#6768Saliva immunoassay for detection of antibodies for cardiovascular disease
#6769Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
#6770Cardiac pressure overload associated genes
#6771Proteins related to schizophrenia and uses thereof
#6772Salt-inducible kinases 2 and use thereof
#6773Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophy
#6774Agonists and antagonists of ryzn for the treatment of metabolic disorders
#6775Metabolite markers for weight management
#6776Detecting superantigen activity in a biological sample
#6777Method for detecting cardiac collateral formation
#6778Methods for diagnosing episodic movement disorders and related conditions
#6779Methods of diagnosing liver fibrosis
#6780Therapeutic agent for ulcerative colitis
#6781Identification of virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
#6782RAGE fusion proteins and methods of use
#6783Therapeutic and prophylactic agents and methods of using the same
#6784Porcine fgl2
#6785Cancer-associated antigens and methods of their identification and use
#6786Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor
#6787Methods of diagnosing & treating diabetes and insulin resistance
#6788Immunoassay
#6789Methods for detecting breast and ovarian cancer
#6790Atlastin
#6791Method of using molecularly imprinted polymers for noninvasive diagnosis
#6792Method and index for diagnosing insulin resistance
#6793Diagnosis and treatment of fanconi's anemia
#6794Survivin, a protein that inhibits cellular apoptosis, and its modulation
#6795Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
#6796Methods for detecting Xanthrochromia
#6797Survivin, a protein that inhibits cellular apoptosis, and its modulation
#6798Methods
#6799Soluble CD14 antigen
#6800Biological markers for longevity and diseases and uses thereof
#6801DRG11-responsive (DRAGON) gene and uses thereof
#6802Diagnostic markers of acute coronary syndrome and methods of use thereof
#6803Biological marker for inflammation
#6804Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
#6805Methods for determining susceptibility to dental caries
#6806Disease markers for early stage atherosclerosis
#6807Allergenic proteins and peptides from dog dander and uses therefor
#6808Modulators that promote cell surface expression of odorant receptors
#6809CaMKII/calcium channel phosphorylation-related compositions and methods
#6810Reagent sets and gene signatures for renal tubule injury
#6811Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors
#6812Methods and compositions for measuring canine BNP and uses thereof
#6813Estrogen receptor interaction with a transcription factor
#6814Novel use of aim 3 acting as a tumor suppressor
#6815Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#6816Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism
#6817Method for detecting the risk of and for treatment of type 2 diabetes
#6818Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2)
#6819Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis
#6820Antagonizing interleukin-21 receptor activity
#6821Compositions and methods for diagnosing and treating an inflammation
#6822Method for identifying modulators of human orexin-2 receptor
#6823Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
#6824Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
#6825Screening method
#6826Anti-human VEGF receptor Flt-1 monoclonal antibody
#6827Sclerostin and the inhibition of WNT signaling and bone formation
#6828GDF3 propeptides and related methods
#6829Assay
#6830Method for diagnosing inflammatory diseases and infections by the determination of LASP-1 immunoreactivity
#6831Prevention and treatment of cardiovascular pathologies
#6832Methods for gauging the effect of a depression treatment by determining the levels of beta-arrestin 1 and G-protein coupled receptor kinase 2
#6833Method for the detection of C-reactive protein in mammalian fluids
#6834Methods for detection of the Ob receptor and the diagnosis of body weight disorders, including obesity and cachexia
#6835Method for the early detection of pancreatic cancer and other gastrointestinal disease conditions
#6836Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
#6837Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as hypermethionemia
#6838Netrin compositions and methods of using the same
#6839Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
#6840Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
#6841Methods and devices for diagnosis of appendicitis
#6842Slc2as as modifiers of the p53 pathway and methods of use
#6843Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons
#6844TNFr/OPG-like molecules and uses thereof
#6845Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#6846Methods and compositions to promote bone homestasis
#6847Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
#6848Multimarker panel for diabetes type 1 and 2
#6849Interleukin-8 homologous polypeptides and therapeutic uses thereof
#6850Diagnosis of disease and monitoring of therapy using gene expression analysis of peripheral blood cells
#6851Compositions and methods for treating and diagnosing cancer
#6852Genes and polypeptides relating to hepatocellular or colorectal carcinoma
#6853Na+ and CI-coupled transport system for endogenous opioid peptides
#6854Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same
#6855Serum marker for measuring liver fibrosis
#6856Methods and compositions to promote bone homeostasis
#6857Human phosphatase RET31, and variants thereof
#6858Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#6859Proteins and nucleic acids encoding same
#6860Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as citrullinemia
#6861Treatment of conditions involving demyelination
#6862Method for determining a risk of atherosclerosis or future development of atherosclerotic complications
#6863Method for interpreting tandem mass spectrometry data for clinical diagnosis
#6864Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#6865Methods of diagnosing inflammatory bowel disease
#6866System and methods for the management and treatment of vascular graft disease
#686715625 receptor, a novel G-protein coupled receptor
#6868Modulation of bone development
#6869Diagnostics and therapeutics for macular degeneration-related disorders
#6870Method and kit for diagnosing myocardial infarction
#6871Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#6872JM-27 as a marker of benign prostatic hyperplasia
#6873Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained
#6874Compositions for controlling hair growth
#6875Real time method of detecting acute inflammatory conditions
#6876Reagents and methods useful for detecting diseases of the urinary tract
#6877Phospholipase Aand gene thereof
#6878Methods and compositions for using alveolar macrophage phospholipase A2
#6879Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1
#6880Biomarkers of chronic pelvic pain syndrome
#6881Method for identifying markers
#6882Skrp, astray, string, vacm associated with metabolic control
#6883Anti-PRO87299 antibodies
#6884Method for the early detection of renal injury
#6885Quantitation of endothelial microparticles
#6886Methods of identifying biomarkers
#6887Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#6888Identifying patients at risk for life threatening arrhythmias
#6889Methods for treating congestive heart failure
#6890Method for diagnosing type II diabetes or monitoring therapeutic effects of therapeutic agents for type II diabetes
#6891Method of assessing the risk of atherosclerosis
#6892Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#6893Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases
#6894Nucleic acid sequences and proteins involved in cellular senescence
#6895NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#6896Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#6897Serum biomarkers for Chagas disease
#6898Methods and materials for diagnosing unstable angina
#6899Methods for diagnosing labor
#6900Method of diagnosing nephrotic syndrome